Company profile
mintneuro
Mint Neurotechnologies Ltd is a UK company with status active founded in 2022 based in London.
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
RP04SH01 | Transaction MzQ0MDY5Njg0MmFkaXF6a2N4
Published 25 Oct 2024 10:53
RP04SH01 | Transaction MzQ0MDY5NDI3OGFkaXF6a2N4
Published 25 Oct 2024 10:48
SH01 | Transaction MzQ0MDgzODcyNmFkaXF6a2N4
Published 24 Oct 2024 12:34
SH02 | Transaction MzQzOTM1NTM5MGFkaXF6a2N4 | Paper/PDF filed
Published 22 Oct 2024 06:37
SH02 | Transaction MzQzOTM1NTM5NGFkaXF6a2N4 | Paper/PDF filed
Published 22 Oct 2024 06:33
RESOLUTIONS | Transaction WUREUU0wWkVhZGlxemtjeA | Paper/PDF filed
Published 22 Oct 2024 06:33
MA | Transaction MzQzOTM1NDg0MmFkaXF6a2N4 | Paper/PDF filed
Published 22 Oct 2024 06:15
SH01 | Transaction MzQ0MDA2OTE2M2FkaXF6a2N4 | Paper/PDF filed
Published 26 Oct 2024 06:30
SH01 | Transaction MzQzOTg1MzQwMGFkaXF6a2N4 | Paper/PDF filed
Published 26 Oct 2024 06:21
SH01 | Transaction MzQzOTM1Mjg1MmFkaXF6a2N4
Published 18 Oct 2024 07:25
SH01 | Transaction MzQzOTM1Mjg1MWFkaXF6a2N4
Published 14 Oct 2024 02:21
Company registered at Companies House
Spinout company currently in formation (2022) to exploit research outcomes from the ENGINI Fellowship. The goal of MINT is to enable the translation of our innovations into clinical solutions and a viable business, empowering novel medical therapies based on ultra-small implantable neurotechnologies. In the short-term, the proposed medical devices will reduce the risk and cost compared to the standard-of-care for monitoring brain activity, e.g., during epilepsy surgery. Our long-term vision is to enable new treatments for epilepsy and other disorders, such as dementia, traumatic brain injury, and mental health
N/A
1 May 2024 to 30 Apr 2025
MintNeuro, a pioneer in neural implant technology, is addressing critical unmet healthcare needs in the neurological sector. Our focus is on developing advanced semiconductor technology to revolutionise neuromonitoring, brain-computer interfaces (BCIs), and neuromodulation implants. This innovation aims to enhance functionality, efficiency, and reduce inv...
1 Apr 2024 to 31 Mar 2026
Neurological conditions are the leading cause of disability and the second cause of deaths worldwide. Monitoring and treating these diseases is incredibly difficult as targets are encased in thick bone and special membranes in the circulatory system block many drugs. Advanced neural implants, comprising electronics placed inside the skull or spine, are an...
1 Mar 2024 to 31 Aug 2024
Neurotechnology refers to a broad range of devices which can directly record and/or modulate the activity of the nervous system. These devices can either be implanted into the brain or nervous system (invasive) or placed on the surface of the skin (non-invasive). Neurotechnologies have been used, and are in development for, many different purposes, both m...
